FC |
Fold change |
FDR |
False discovery rate |
TCGA |
The Cancer Genome Atlas |
ACC |
Adrenocortical carcinoma |
BLCA |
Bladder cancer |
BRCA |
Breast cancer |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
CHOL |
Cholangiocarcinoma |
COAD |
Colon adenocarcinoma |
DLBC |
Lymphoid neoplasm diffuse large B-cell lymphoma |
ESCA |
Esophageal carcinoma |
GBM |
Glioblastoma |
HNSC |
Head and neck squamous cell carcinoma |
KICH |
Kidney chromophobe carcinoma |
KIRC |
Kidney renal clear cell carcinoma |
KIRP |
Kidney renal papillary cell carcinoma |
LAML |
Acute myeloid leukemia |
LIHC |
Liver hepatocarcinoma |
LUAD |
Lung adenocarcinoma |
LUSC |
Lung squamous cell carcinoma |
OV |
Ovarian cancer |
PAAD |
Pancreas adenocarcinoma |
PCPG |
Pheochromocytoma and paraganglioma |
PRAD |
Prostate adenocarcinoma |
READ |
Rectum adenocarcinoma |
SARC |
Sarcoma |
SKCM |
Skin cutaneous melanoma |
STAD |
Stomach adenocarcinoma |
TGCT |
Testicular germ cell tumors |
THCA |
Thyroid cancer |
THYM |
Thymoma |
UCEC |
Uterine corpus endometrial carcinoma |
UCS |
Uterine carcinosarcoma |
UVM |
Uveal melanoma |